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Abstract. The development of antifungal agents has lagged behind that of antibacterial agents, 
because fungi generally grow slowly and often in multicellular forms, they are more difficult to 
quantify than bacteria. This experiment was designed to evaluate the in vitro properties of the amino 
acids complexes as potential antifungal agent. We tested 4 amino acid complexes: Cu-lysine, Cu-
methionine, Co-lysine and Co-methionine, at different concentrations. The end-points for cytotoxicity 
evaluation are: proliferation rate, lactate dehidrogenase activity (LDH). These two end-points gave 
similar results with the proliferation rate but the last methods seem to be more sensible. Cupper 
complexes especially those with methionine proved to have the higher activity against Candida 
albicans from all the amino acids complexes. 
 
INTRODUCTION 
 
Candida albicans is a single celled fungus that is present in the intestinal and genital 
tracts (Baker et al., 2002). If it is present in disproportionate quantities it can cause infection. 
Vaginitis and thrush are some of the possible manifestations of Candida infection. Because 
candidiasis can affect various parts of the body, the most common being the mouth, ears, 
nose, toenails, fingernails, gastrointestinal tract and vagina, it can be characterised by a wide 
variety of symptoms (Onishi, et al., 2000). These include constipation, diarrhoea, colitis, 
abdominal pain, headaches, bad breath, rectal itching, acne, night sweats, clogged sinuses, 
kidney and bladder infections, adrenal problems and even diabetes (Cowan, 1999). Symptoms 
often worsen in damp places or after consumption of foods that contain sugar and/or yeast. 
Because of these many various symptoms, this disorder is often misdiagnosed. Candidiasis 
may affect both men and women. It is most common in those who have a compromised 
immune system, and as it proliferates, the fungus releases toxins that weaken the immune 
system further. Very often, people with candida infections also have food allergies (Guerra, et 
al., 2002; Jahanara et al., 2004; Onishi et al., 2000). 
During the last two decades, antifungal therapy for serious disseminated infections has 
relied on the use of agents that either disrupt membrane function by binding preferentially to 
ergosterol or inhibit the biosynthesis of this fungal sterol. Some fungicidal agent must be used 
cautiously due to dose-limiting nephrotoxicity (Cowan, 1999; Sharma et al., 2005). 
The development of antifungal agents has lagged behind that of antibacterial agents 
(Onishi et al., 2000). This is a predictable consequence of the cellular structure of the 
organisms involved. Bacteria are prokaryotic and hence offer numerous structural and 
metabolic targets that differ from those of the human host. Fungi, in contrast, are eukaryotes, 
and consequently most agents toxic to fungi are also toxic to the host (Tapia et al., 2004). 
Furthermore, because fungi generally grow slow and often in multicellular forms, they are 
more difficult to quantify than bacteria. This difficulty complicates experiments designed to 
evaluate the in vitro or in vivo properties of a potential antifungal agent (Braicu et al., 2005; 
Vidotto et al., 2003). 
Coordination complexes of transition metals have been widely studied for their 
antimicrobial, antifungal and potent cytotoxic chemotherapeutic agents to treat (Veeraraj et 
al., 2004; Shamim Hossain et al., 2004). The aim of the present study was to evaluate the 
antifungal effect of some amino acids complexes comparing with free ligand and as reference 
standard it was used Hexoral as antifungal agent from the market (Chanmyia et al., 2004; 
Braicu et al., 2006). 
 
MATERIALS AND METHODS 
 
Cell culture: Candida albicans (CA) selected strain (ATCC10231, CULTILOOPS), 
standardised cell culture medium, Hexoral as positive control  (antifungal product on the 
market at 1:10 dilution). 
CA is co-cultivated in the presence three concentration: 10-3, 2X10-3, 3X10-3M, of 
different amino acid-metal complex, three similar molar concentration of free amino acid and 
three similar concentration of metal (10 µl/ml complex, free amino acid or metal in the cell 
culture medium). 
Proliferation rate is measured photometrical at 3 and 6 hours and again after 24 
hours, using a calibration curve for yeast cell number.    
LDH activity is determined using the reaction:   
Pyruvate + NADH + H+ → L-lactate + NAD+ 
Speed of NADH oxidation is direct proportional with enzymatic activity of the LDH. 
Spectrophotometric determination was made at 340 mn. 
For lipid peroxidation it was used 1 ml yeast homogenate mixed with 2 ml working 
solution containing 15%  (w/v) thiobarbituric acid, 0.25 N HCl. The mixture was heated for 
15 minute in boiling water. After cooling, the precipitate was removed by centrifugation at 
1000 g for 10 min. Absorbance was determined at 535 nm. 
Copper and cobalt amino acids synthesis. It was synthesized 4 types of amino acids 
complexes using copper and cobalt ions and methionine lysine as ligand: Cu-lys, Cu-met, Co-
lys and Co-met. Amino acid water solutions were deprotonated with NaOH 6M solution, and 
then metals salts solution was added, stirred and heated at 300C. If the precipitate doesn’t 
form it was added organic solvents for precipitation. After filtration the solid phase was 
washed with ethanol and dried at 400C. 
 
RESULTS AND DISSCUSION 
 
1. Cell proliferation 
In case of proliferation rate we had plot the cell density versus time and is presented in 
Figure 1. 
Based on date from the proliferation rate curve we can calculate the inhibition percent of 
CA proliferation reporting to positive martor. We have chosen a positive martor as antifungal 
agent from the market (Hexoral). In the case of Heoxoral inhibition of proliferation growth 
rate (I) at 3 hours I3= 53%, at 8 hours I8= 39 % and I24= 34%. For the methionine as we 
expected we had no inhibition of proliferation rate for all three doses. For all doses we 
obtained activation of proliferation growth rate (A), the A values were between 1.58-26%. 
For intermediated doses of lysine it was obtained unexpected low inhibition: I3= 8%, at 8 
hours I8= 1 % and I24= 7%. For the other doses we had A value between 0.5-3 and we can say 
that growth curve is relatively similar with the control. Copper inhibition was between 10-
35%, with no directly relation dose-effect, but the inhibition was increased in time I3= 10%, 
I8= 25 % and I24= 30%. The effect of copper was similar with Hexoral. For cobalt at 3 hour 
we had A3 between 7-71%, A8 between 10-12%, but at 24 we had an inhibition I between 10-
24%.  
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Figure 1 Proliferation rate amino acids complexes: A: Cu-lysine, B: Cu-methionine, C: Co-lysine and D: Co-
methionine, at 3 different concentrations. 
 
For all the amino acids in the fists phase at 3 hours we had low increasing of 
proliferation rate but in different proportion.  
At 8 hours was observed an inhibition for the: 
 Co-Lys the I8=1% average for all three doses,  
 Cu-Lys I8=6 % (dose10-3), 10 % (dose 2X10-3), 18 % (dose 3X10-3M); Cu-lys 
proved to have a higher inhibition of growth than Co-lys and Co-Met but lower 
than Cu-Met.  
 Cu-Met has the higher inhibition of growth rate I8=17% (dose10-3 M), 23% 
(dose 2X10-3 M), 30% (dose 3X10-3M);  
 Co-Met I8=2% (dose10-3 M), 4% (dose 2X10-3 M), 4 % (dose 3X10-3M).  
At 24 hours: 

 Co-Lys I24=9% (dose10-3 M), 13 % (dose 2X10-3 M), 13 % (dose 3X10-3M); 

 Cu-Lys I24=8% (dose10-3 M), 10 % (dose 2X10-3 M), 14 % (dose 3X10-3M); 

 Cu-Met I24=10 % (dose10-3 M), 14% (dose 2X10-3 M), 22% (dose 3X10-3M); 

 Co-Met I24=8 % (dose10-3), 13% (dose 2X10-3 M), 14% (dose 3X10-3M); 
 
2. LDH activity  
Level of LDH from extracelular medium is expressed in nm NADH/min/10000 cells 
and is presented in figure 2. 
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Figure 2. LDH activity for the copper amino acid complexes. A: Cu-lysine, B: Cu-methionine, C: Co-lysine and 
D: Co-methionine, at 3 different concentrations 
 
Release of LDH in the medium is a cytotoxicity marker. The higher level on LDH 
activity was in the case of Cu-Met. Based on this assay we can say that the higher level of cell 
death was in co-cultivation with Cu-met complex. In the case of Cu-lys the value is lower 
than Cu-Met, but higher than other two complexes. 
This end-point gave similar results with the proliferation rate but the last methods 
seem to be more sensible.  
 
CONCLUSION 
 
Cobalt complexes were proved a low efficiency against CA. 
Cupper complexes especially those with methionine were proved the higher activity 
against CA from all the amino acids complexes. 
These complexes are efficient on against CA on long term because as the higher 
inhibition of growth rate is at 24 hours. The Candida albicans growth is more affected after 
24h of action, and it can be used on long treatment. 
Hexoral inhibition is decreasing during the time, but the effect of amino acid complexes 
are opposite it was proved an increasing of efficacy during the time, the critical point of cell 
growth inhibition was between 12-24 hours. 
This means that these complexes are efficient on long time. For obtaining the best 
results these two types of agents can be used in the same time especially in the case when 
there is a treatment resistance.  
As final conclusion, these amino acids complexes can be used as alternative antifungal 
agents against Candida albicans, especially for treatment resistance. 
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